Business Context and Reporting Period
This Form 8-K filing by Glucotrack, Inc. (GCTK) is dated December 31, 2024. The report addresses a regulatory notice received from the Nasdaq Stock Market LLC regarding the Company's compliance with continued listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the status of the Company's stock listing.
Material Changes
On December 31, 2024, Nasdaq notified Glucotrack, Inc. that the bid price for its common stock had closed below the minimum $1.00 per share requirement for at least 30 consecutive business days. This constitutes a failure to satisfy Nasdaq Listing Rule 5550(a)(2), known as the "Bid Price Rule."
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has been granted an initial 180-day compliance period, ending June 30, 2025, to regain compliance.
- Path to Compliance: Compliance can be achieved if the bid price closes at $1.00 or more for ten consecutive business days before the deadline.
- Secondary Options: If the initial period expires without compliance, the Company may be eligible for an additional 180-day period. This would require meeting market value and other initial listing standards, potentially necessitating a reverse stock split.
- Delisting Risk: Failure to regain compliance by the required deadlines could result in delisting. The Company retains the right to appeal a delisting determination to a Nasdaq hearings panel.
- Current Status: The notice has no immediate effect on the listing; the stock continues to trade on the Nasdaq Capital Market under the symbol "GCTK."
- Management Expectation: Management expects to cure the deficiency within the 180-day period but notes there can be no assurance of success.
Investor Verification Checklist
- Verify the current closing bid price of GCTK stock to assess proximity to the $1.00 threshold.
- Monitor the Company's announcements regarding the potential execution of a reverse stock split if the initial compliance period is insufficient.
- Review the Company's market value of publicly held shares to determine eligibility for a second compliance period.
- Track the timeline for the June 30, 2025, deadline for the initial compliance period.